Company Profile
Intelligent Bio Solutions Stock Price, News & Catalysts
- Ticker:
- INBS
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
1.66 USD (-0.60%)
Close
Last updated: October 1, 2026
6.08M USD
Market cap
Why the stock is moving
As of Oct 1, 2026, INBS closed down 0.60% at $1.66. No new same-company headline was identified in the current news window.
Company overview
Fingerprint Drug Screening Company
Intelligent Bio Solutions develops rapid, non-invasive drug-testing systems that analyze fingerprint sweat. Its platform is used in workplace and safety-sensitive environments outside the United States.
Intelligent Fingerprinting System
The system combines a disposable collection cartridge with a portable reader and software. A fingerprint sweat sample is collected in seconds, and the reader can provide screening results in under ten minutes.
Drug Detection Menu
Commercial cartridges screen for commonly abused substances including opiates, cocaine, methamphetamine, and cannabis. The company is pursuing an initial U.S. clearance for codeine detection.
Reader-and-Cartridge Model
INBS places or sells readers and generates recurring revenue from single-use cartridges. Growth in the installed base increases the opportunity for repeat consumable sales as customers conduct routine testing.
Workplace and International Markets
Customers include logistics, construction, manufacturing, drug-treatment, and other organizations where impairment creates safety risks. The business is established in the United Kingdom and other markets while preparing for U.S. entry.
Future catalysts
- FDA 510(k) submission for the Intelligent Fingerprinting Drug Screening System in the second half of 2026.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Intelligent Bio Solutions (INBS)?
Intelligent Bio Solutions (INBS) most recently closed at 1.66 USD, a -0.60% move versus the previous session.
What is the market cap of Intelligent Bio Solutions (INBS)?
Intelligent Bio Solutions currently has a market capitalization of 6.08M USD on BioPharmSignal.
What does Intelligent Bio Solutions do?
Fingerprint Drug Screening Company Intelligent Bio Solutions develops rapid, non-invasive drug-testing systems that analyze fingerprint sweat. Its platform is used in workplace and safety-sensitive environments outside the United States. Intelligent Fingerprinting System The system combines a disposable collection cartridge with a portable reader and...
On which exchange is INBS stock listed?
Intelligent Bio Solutions (INBS) is associated with NASDAQ, United States, MedTech.
What is Fingerprint?
FDA 510(k) submission for the Intelligent Fingerprinting Drug Screening System in the second half of 2026.
Which conditions is Intelligent Bio Solutions targeting with Fingerprint?
FDA 510(k) submission for the Intelligent Fingerprinting Drug Screening System in the second half of 2026.
How does Intelligent Bio Solutions describe recent progress with Fingerprint?
FDA 510(k) submission for the Intelligent Fingerprinting Drug Screening System in the second half of 2026.
What is Drug?
Fingerprint Drug Screening Company Intelligent Bio Solutions develops rapid, non-invasive drug-testing systems that analyze fingerprint sweat.